Bradykinin Receptor Antagonists
- Name
- Bradykinin Receptor Antagonists
- Accession Number
- DBCAT001656
- Description
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.
- Drugs
Drug Drug Description Anatibant Investigated for use/treatment in traumatic brain injuries. Deltibant Deltibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Deltibant is a bradykinin receptor antagonist. Deltibant has a monoisotopic molecular weight... Fasitibant Fasitibant is under investigation in clinical trial NCT02205814 (Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee). Icatibant A bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE). - Drugs & Drug Targets
Drug Target Type Anatibant B2 bradykinin receptor target Deltibant B2 bradykinin receptor target Fasitibant B2 bradykinin receptor target Icatibant B2 bradykinin receptor target Icatibant Aminopeptidase N target